ArticleJournal of cancer research and clinical oncology2021

Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer.

Yu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.